Recent Finacing
Recent Raise
Oncology Venture redevelops failed oncology drugs through targeted‑enrollment phase 2 trials using its DRP biomarker platform to generate tumor gene‑signature predictors for patient screening, selection, and trial enrollment.
Focus Areas
Total Raised
Funding round